| Matrix Composites & Engineering Limited (MCE) ORDINARY FULLY PAID |
Energy |
$55 |
Appendix 3Y - Aaron Begley
|
7 Oct 2024 10:03AM |
$0.355 |
$0.245 |
fallen by
30.99%
|
|
| AMCIL Limited (AMH) ORDINARY FULLY PAID |
Financials |
$346 |
Weekly Estimated NTA as at 4 October 2024
|
7 Oct 2024 10:03AM |
$1.145 |
$1.080 |
fallen by
5.68%
|
|
| Bowen Coking Coal Limited (BCB) ORDINARY FULLY PAID |
Materials |
$8 |
Reinstatement to Quotation
|
7 Oct 2024 10:02AM |
$0.012 |
$0.075 |
risen by
525%
|
|
BCB - Price-sensitive ASX Announcement
Full Release
Key Points
- Suspension of trading in BCB securities will be lifted.
- Lifting of suspension follows an announcement regarding equity financing.
- Announcement made on 7 October 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bowen Coking Coal Limited (BCB) ORDINARY FULLY PAID |
Materials |
$8 |
Proposed issue of securities - BCB
|
7 Oct 2024 10:01AM |
$0.012 |
$0.075 |
risen by
525%
|
|
| Bowen Coking Coal Limited (BCB) ORDINARY FULLY PAID |
Materials |
$8 |
Entitlement Offer Prospectus
|
7 Oct 2024 10:01AM |
$0.012 |
$0.075 |
risen by
525%
|
|
BCB - Price-sensitive ASX Announcement
Full Release
Key Points
- Entitlement offer of 2.66 New Shares for every 1 Share held by Eligible Shareholders.
- Issue price of $0.009 per New Share to raise approximately $70 million.
- Free attaching New Option for every 2 New Shares subscribed.
- Partially underwritten with a minimum subscription of $60 million required.
- Funds will be used for mine development costs, liquidity, and covering offer costs.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bowen Coking Coal Limited (BCB) ORDINARY FULLY PAID |
Materials |
$8 |
Equity Capital Raising Presentation
|
7 Oct 2024 10:00AM |
$0.012 |
$0.075 |
risen by
525%
|
|
BCB - Price-sensitive ASX Announcement
Full Release
Key Points
- BCB plans to raise approximately $70 million through a renounceable entitlement offer.
- The offer price is A$0.009 per new share, a 25% discount to the last traded price.
- The capital raising aims to support operations in the Burton Mine Complex.
- The company is facing challenges from declining coal prices and higher operational costs.
- BCB has put some assets into care and maintenance to manage costs.
- The company is actively pursuing liquidity options and debt restructuring.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Manuka Resources Ltd (MKR) ORDINARY FULLY PAID |
Materials |
$58 |
TTR's Taranaki VTM Project in NZ Govt's Fast Projects List
|
7 Oct 2024 10:00AM |
$0.043 |
$0.054 |
risen by
25.58%
|
|
MKR - Price-sensitive ASX Announcement
Full Release
Key Points
- Manuka Resources Limited owns the Taranaki VTM Project.
- The Taranaki VTM Project is located in the South Taranaki Bight of New Zealand.
- The company has significant gold and silver assets in New South Wales.
- The Taranaki VTM Project is included in the NZ Govt's Fast Projects List.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pilot Energy Limited (PGY) ORDINARY FULLY PAID |
Energy |
$15 |
Pause in Trading
|
7 Oct 2024 9:58AM |
$0.022 |
$0.007 |
fallen by
68.18%
|
|
PGY - Price-sensitive ASX Announcement
Full Release
Key Points
- Pilot Energy Limited has paused trading in its securities.
- The trading pause is pending a further announcement.
- This is a standard procedure in response to corporate developments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bowen Coking Coal Limited (BCB) ORDINARY FULLY PAID |
Materials |
$8 |
Partially underwritten A$70 million Equity Raising
|
7 Oct 2024 9:58AM |
$0.012 |
$0.075 |
risen by
525%
|
|
BCB - Price-sensitive ASX Announcement
Full Release
Key Points
- Bowen Coking Coal announces a partially-underwritten A$70 million equity raising.
- The offer includes a 2.66 for 1 pro rata renounceable entitlement.
- Use of proceeds includes funding for Plumtree North mine development, pre-payments, and working capital.
- The company has achieved steady production levels at the Ellensfield South pit.
- Bowen has improved its strip ratio at the Burton Complex from 15:1 to 6.7:1.
- The entitlement offer represents a 25.0% discount to the last closing price.
- Major shareholders have committed approximately A$40.5 million.
- The entitlement offer is intended to strengthen the company's balance sheet.
- Bowen aims to capitalize on recent rebounds in coking coal prices.
- Total proceeds from the offer will be allocated to various operational and capital needs.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Amcor Plc (AMC) CDI 1:1 FOREIGN EXEMPT NYSE |
Materials |
$8,487 |
Statement of CDIs on issue - AMC
|
7 Oct 2024 9:57AM |
$16.200 |
$12.140 |
fallen by
25.06%
|
|
| Botala Energy Ltd (BTE) ORDINARY FULLY PAID |
Energy |
$16 |
Serowe Energy Hub Environmental Approval
|
7 Oct 2024 9:57AM |
$0.070 |
$0.059 |
fallen by
15.71%
|
|
| Energy Resources of Australia Limited (ERA) ORDINARY FULLY PAID 'A' |
Energy |
$1,013 |
Review Panel decides to conduct proceedings
|
7 Oct 2024 9:57AM |
$0.010 |
$0.003 |
fallen by
75%
|
|
ERA - Price-sensitive ASX Announcement
Full Release
Key Points
- ERA announced a $880 million share offer.
- Zentree Investments Limited and Packer & Co Ltd filed a review application.
- The Review Panel will conduct proceedings on the application.
- Independent Board Committee to revise the Entitlement Offer timetable.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Alderan Resources Limited (AL8) ORDINARY FULLY PAID |
Materials |
$5 |
Alderan Intersects 25m Copper Mineralised Zone at New Years
|
7 Oct 2024 9:56AM |
$0.004 |
$0.026 |
risen by
642.86%
|
|
AL8 - Price-sensitive ASX Announcement
Full Release
Key Points
- High grade copper oxide mineralisation confirmed from 0-25m down hole NY2024-DDH3.
- Averaged pXRF drill core assay intervals up to 8.2% copper.
- Second zone of primarily sulphide mineralisation from 73-92m down hole with averaged pXRF intervals up to 17.2% copper.
- Copper mineralisation occurs in tourmaline breccia, similar to the historical Cactus copper-gold mine.
- Archaeological site inspection for Stage 2 drilling has been completed.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cann Group Limited (CAN) ORDINARY FULLY PAID |
Health Care |
$13 |
Target market determination
|
7 Oct 2024 9:53AM |
$0.069 |
$0.019 |
fallen by
72.46%
|
|
CAN - Price-sensitive ASX Announcement
Full Release
Key Points
- Cann Group Limited is offering unlisted options to acquire shares.
- The TMD is aimed at current shareholders and sophisticated investors.
- The investment is suitable for those seeking medium-term exposure to equities in a cannabis company.
- Investors should understand the speculative risks involved.
- New options expire 24 months after issuance.
- Eligible shareholders can subscribe for new shares under the Entitlement Offer.
- Investors must have sufficient funds to exercise their options.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cann Group Limited (CAN) ORDINARY FULLY PAID |
Health Care |
$13 |
Prospectus
|
7 Oct 2024 9:52AM |
$0.069 |
$0.019 |
fallen by
72.46%
|
|
CAN - Price-sensitive ASX Announcement
Full Release
Key Points
- The Prospectus is dated 7 October 2024 and lodged with ASIC.
- The entitlement offer consists of one new share for every three shares held at an issue price of $0.04 per new share.
- The Offer aims to raise approximately $6.25 million before costs.
- Cann Group plans to use the raised funds for cultivation costs and working capital.
- The company is focusing on expanding its production capacity at the Mildura facility.
- Cann's commercial strategy includes selling medicinal cannabis under its Botanitech brand.
- The Offer is extended to shareholders with registered addresses in Australia and New Zealand.
- Funds will support the launch of new products and meet the production targets for FY2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Rhythm Biosciences Limited (RHY) ORDINARY FULLY PAID |
Health Care |
$29 |
2nd Generation, ColoSTAT Multiplex Alpha Kit Outperforms
|
7 Oct 2024 9:51AM |
$0.076 |
$0.090 |
risen by
18.42%
|
|
RHY - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of ColoSTAT® Multiplex Alpha Kit Performance Evaluation exhibits superior analytical results to original ColoSTAT® Kits
- Rhythm advances towards Beta Kit assay production and final validation
- ColoSTAT® 2nd generation kits show greater than 70% probability of superior performance characteristics
- Novel algorithm for sample classification was developed
- Testing performed on 200 previously collected patient serum samples
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Oncosil Medical Limited (OSL) ORDINARY FULLY PAID |
Health Care |
$31 |
OncoSil signs distribution agreement with Al Zahrawi Medical
|
7 Oct 2024 9:50AM |
$0.014 |
$1.655 |
risen by
11,721.43%
|
|
| Echo IQ Limited (EIQ) ORDINARY FULLY PAID |
Information Technology |
$123 |
Pause in Trading
|
7 Oct 2024 9:48AM |
$0.240 |
$0.190 |
fallen by
20.83%
|
|
EIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- ECHOIQ Limited announced a pause in trading.
- The pause is temporary and pending further announcement.
- The announcement is aimed at ensuring compliance with ASX regulations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| TechGen Metals Ltd (TG1) ORDINARY FULLY PAID |
Materials |
$10 |
Station Creek Critical and Precious Metals update
|
7 Oct 2024 9:48AM |
$0.034 |
$0.030 |
fallen by
11.76%
|
|
TG1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Confirmation of Antimony with a peak of 2.54% and six other samples recording +1,000ppm Sb.
- XRD analysis identified Tetrahedrite, a sulfosalt mineral associated with copper and antimony.
- Notable mineral credits include a peak copper reading of 15.5%, gold at 2.07g/t, and silver at 104g/t.
- A significant +15ppm antimony soil anomaly measuring 1.2km x 400m has been identified.
- Ground IP geophysics is planned to target areas rich in antimony associated with silver, gold, and copper.
- The project area has unexplored potential, particularly for antimony, copper, silver, and gold.
- Antimony is classified as a Critical Mineral by the USA, EU, and Australia, highlighting its strategic importance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cann Group Limited (CAN) ORDINARY FULLY PAID |
Health Care |
$13 |
Proposed issue of securities - CAN
|
7 Oct 2024 9:47AM |
$0.069 |
$0.019 |
fallen by
72.46%
|
|
| EQ Resources Limited (EQR) ORDINARY FULLY PAID |
Materials |
$106 |
EQR Identifies 5 Exploration Targets for Wolfram Camp
|
7 Oct 2024 9:47AM |
$0.057 |
$0.029 |
fallen by
49.12%
|
|
EQR - Price-sensitive ASX Announcement
Full Release
Key Points
- EQR has secured an Exploration Permit for the Wolfram Camp mine.
- The 477km² license includes key exploration targets in the Herberton Tin-Tungsten field.
- EQR aims to leverage operational success from the Mt Carbine Tungsten mine.
- Plans include evaluating low-grade stockpiles and historical resources.
- The initiative supports regional economic growth and aligns with Queensland’s Critical Minerals Strategy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EnviroSuite Limited (EVS) ORDINARY FULLY PAID |
Information Technology |
$131 |
CFO steps down
|
7 Oct 2024 9:46AM |
$0.072 |
$0.090 |
risen by
24.31%
|
|
| Live Verdure Ltd (LV1) ORDINARY FULLY PAID |
Consumer Staple |
$144 |
Reinstatement to Quotation
|
7 Oct 2024 9:45AM |
$0.550 |
$0.915 |
risen by
66.36%
|
|
LV1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Live Verdure Ltd is reinstated for trading.
- Suspension lifted after announcement of proposed capital raising.
- Trading will resume on ASX immediately.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Live Verdure Ltd (LV1) ORDINARY FULLY PAID |
Consumer Staple |
$144 |
Live Verdure Raises $3.0m and Decidr Update
|
7 Oct 2024 9:45AM |
$0.550 |
$0.915 |
risen by
66.36%
|
|
LV1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Live Verdure raised $3,018,348 through options exercise.
- 10,061,161 shares to be issued at 30 cents per share.
- Further commitments of $1,050,000 expected from additional options.
- Capital raise strengthens the balance sheet for growth strategy.
- Decidr partners with Elmo Software for AI-driven recruitment solutions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Chimeric Therapeutics Limited (CHM) ORDINARY FULLY PAID |
Health Care |
$10 |
AML patient achieves Complete Response in CHM CORE-NK trial
|
7 Oct 2024 9:45AM |
$0.014 |
$0.003 |
fallen by
78.57%
|
|
CHM - Price-sensitive ASX Announcement
Full Release
Key Points
- Chimeric Therapeutics announced a Complete Response from an AML patient in the CHM CORE-NK trial.
- The Phase 1b trial combines NK cells with Vactosertib, a TGF-ß receptor inhibitor.
- This trial is the first to assess NK cells with Vactosertib in blood cancers.
- The ongoing trial aims to enroll 12 patients, with 3 currently enrolled.
- A previous Phase 1a study showed safety and no GvHD, with effective disease control in all patients.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
